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Hematopoiesis  is  regulated  through  dynamic 
cell–cell interactions between developing blood 
cells  and  stromal  cells  in  the  bone  marrow. 
Soluble factors that are elaborated in this mi-
croenvironment are also critically involved in 
sustaining developing hematopoietic precursors 
and guiding the differentiation of their prog-
eny. Concerning NK cell development, both 
stromal cells and cytokine/growth factors play 
essential roles. Among the latter, IL-15 has been 
identified as a dominant cytokine in NK cell de-
velopment, driving the generation of NK cells 
from committed NK cell precursors, promot-
ing the differentiation of immature NK cells, 
and maintaining the survival of mature NK cells 
in the peripheral lymphoid organs (Kennedy   
et al., 2000; Cooper et al., 2001; Ranson et al., 
2003; Vosshenrich et al., 2005). IL-15 signals 
are delivered through transpresentation, where 
cell surface–bound IL-15–IL-15R complexes 
trigger  responsive  cells  (Dubois  et  al.,  2002; 
Mortier et al., 2008). Both hematopoietic cells 
(including macrophages and dendritic cells) and 
nonhematopoietic cells (stromal cells, epithelial 
cells) transpresent IL-15 to assure homeostasis 
of NK cells and other IL-15–dependent cells 
(Huntington et al., 2009). The demonstration 
that several sources of IL-15–IL-15R exist in 
peripheral tissues provides a possibility to pro-
mote NK cell differentiation from circulating 
NK cell precursors outside the bone marrow. 
This  “NK-poeisis”  has  been  suggested  to 
occur in the thymus in mice (Di Santo and   
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The natural cytotoxicity receptor NKp46 (encoded by Ncr1) was recently shown to identify 
a subset of noncytotoxic, Rag-independent gut lymphocytes that express the transcription 
factor Rorc, produce interleukin (IL)-22, and provide innate immune protection at the 
intestinal mucosa. Intestinal CD3NKp46+ cells are phenotypically heterogeneous, compris-
ing a minority subset that resembles classical mature splenic natural killer (NK) cells 
(NK1.1+, Ly49+) but also a large CD127+NK1.1 subset of lymphoid tissue inducer (LTi)–
like Rorc+ cells that has been proposed to include NK cell precursors. We investigated  
the developmental relationships between these intestinal CD3NKp46+ subsets. Gut 
CD3NKp46+ cells were related to LTi and NK cells in requiring the transcriptional  
inhibitor Id2 for normal development. Overexpression of IL-15 in intestinal epithelial cells 
expanded NK1.1+ cells within the gut but had no effect on absolute numbers of the 
CD127+NK1.1Rorc+ subset of CD3NKp46+ cells. In contrast, IL-7 deficiency strongly 
reduced the overall numbers of CD3NKp46+NK1.1 cells that express Rorc and produce 
IL-22 but failed to restrict homeostasis of classical intestinal NK1.1+ cells. Finally, in vivo 
fate-mapping experiments demonstrated that intestinal NK1.1+CD127 cells are not the 
progeny of Rorc-expressing progenitors, indicating that CD127+NK1.1Rorc+ cells are not 
canonical NK cell precursors. These studies highlight the independent cytokine regulation 
of functionally diverse intestinal NKp46+ cell subsets.
© 2010 Satoh-Takayama  This article is distributed under the terms of an At-
tribution–Noncommercial–Share Alike–No Mirror Sites license for the first six 
months after the publication date (see http://www.rupress.org/terms). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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LTi cells are classically defined as CD3CD4+ hemato-
poietic cells that promote the formation of lymphoid tissues 
through a cross talk with lymphoid tissue stromal cells, result-
ing in the recruitment of B and T lymphocytes that segre-
gate into functionally distinct zones (for review see Mebius, 
2003). Rorc is critical to this process, as LTi cells from Rorc-
deficient mice are not generated and stromal cells in lym-
phoid tissue anlagen fail to induce stromal cell expression of 
vascular  cell  adhesion  molecule  and  intracellular  adhesion 
molecule, resulting in abortive lymphoid tissue genesis. Cy-
tokines also play an important role in this process. LTi cells 
express CD127 and IL-7 is required for the activation of LTi 
cells to express membrane-bound lymphotoxin LT12 het-
erotrimer (Luther et al., 2003). This form of lymphotoxin ac-
tivates stromal cells through the LTR in a process required 
for the development of lymph nodes, Peyer’s patches, and in-
testinal isolated lymphoid follicles (Eberl and Lochner, 2009). 
Similar to CD127+NK1.1 cells, LTi cells have been shown 
to express IL-22 and IL-17 (Cupedo et al., 2009; Takatori et al., 
2009). However, a role for IL-17 and/or IL-22 in the devel-
opment of lymphoid tissues remains to be demonstrated.
The developmental relationship of LTi cells to other 
hemato-lymphoid subsets is not fully understood. The transcrip-
tional inhibitor Id2 plays a critical role in LTi generation and is 
also essential at an early stage of NK cell commitment (Yokota 
et al., 1999), suggesting a link between LTi and NK cell devel-
opmental pathways. Consistent with this notion, a population 
of fetal CD3CD4+ cells with LTi activity could generate lytic 
NK1.1+ cells after culture in IL-2 (Mebius et al., 1997; 
Yoshida et al., 2001). Analysis of human lymph nodes and 
tonsils identified a population of immature NK cells that ex-
press CD127 and Rorc that can further develop into mature 
CD56+ NK cells that express inhibitory CD94–NKG2A com-
plexes (Hughes et al., 2009). Lastly, recent results showed that 
human fetal tissues harbor a lineage-negative CD127+ LTi cell 
population  enriched  in  Rorc  expression  that  can  generate 
CD56+ NK cells in vitro (Cupedo et al., 2009). Thus, data in 
both humans and mice suggest that LTi-like Rorc+ cell subsets 
potentially harbor precursors to mature NK cells.
Considering the immature NK cell phenotype of most 
intestinal CD3NKp46+ cells and their phenotypic similari-
ties  to  LTi  cells,  a  hypothesis  has  emerged  that  intestinal 
CD3NKp46+ cells expressing Rorc may include NK cell 
precursors that could develop locally into specialized NK cell 
subsets under the influence of microbial stimulation (Colonna, 
2009; Vivier et al., 2009). In this report, we define the devel-
opmental relationships between the different identified intes-
tinal NKp46+ cell subsets using cytokine-deficient mice and 
in vivo fate-mapping approaches.
RESULTS AND DISCUSSION
Essential role for the transcriptional inhibitor Id2  
in the homeostasis of intestinal CD3NKp46+ cells  
that express Rorc and Il22
To understand the developmental relationship between dis-
tinct intestinal CD3NKp46+ subsets, we first assessed the 
Vosshenrich, 2006) and the lymph nodes in mice and humans 
(Freud et al., 2005; Freud and Caligiuri, 2006; Veinotte et al., 
2008), and could also operate at epithelial surfaces.
Although IL-15 is required for development of all NK1.1+ 
cells (Kennedy et al., 2000; Vosshenrich et al., 2005), addi-
tional cytokines have been identified that are critical for the 
homeostasis of distinct, tissue-resident NK cell subsets. Thymic 
NK1.1+ cells are characterized by CD127 (IL-7R chain) ex-
pression and develop independently of Rag-dependent T cell 
progenitors (Vosshenrich et al., 2006). Unlike bone marrow or 
splenic NK cells, the homeostasis of thymic CD127+ NK cells 
requires IL-7 (Vosshenrich et al., 2006). Whether other NK 
cell subsets have particular cytokine requirements for their ho-
meostasis or for their effector functions is unknown.
The  natural  cytotoxicity  receptor  (NCR)  NKp46  (en-
coded by the Ncr1 locus) has been shown to be highly and 
specifically expressed in NK cells from several species (Moretta 
and Moretta, 2004), and has been proposed in a universal defi-
nition for NK cells (CD3NKp46+; Walzer et al., 2007). Al-
though this may be applicable to CD3NKp46+ cells from 
the bone marrow, blood, or spleen (which appear as relatively 
homogeneous  populations  of  cytotoxic  NK1.1+  NK  cells), 
recent studies have identified substantial diversity in the in-
testinal CD3NKp46+ compartment (Satoh-Takayama et al., 
2008; Luci et al., 2009; Sanos et al., 2009). Using CD127 and 
NK1.1, we were able to discriminate several subsets of intes-
tinal CD3NKp46+ cells (CD127+NK1.1, CD127+NK1.1+, 
and CD127NK1.1+) that showed distinct cell-surface pheno-
types and functional attributes (Satoh-Takayama et al., 2008). 
CD127NK1.1+ cells were similar to CD3NK1.1+ NK cells 
found in the spleen, bearing mature NK markers (NKG2D, 
CD11b, Ly49 family members) and effector functions (per-
forin, IFN-). A predominant CD127+NK1.1 subset was 
clearly different, bearing few or no NK cell markers, lacking 
perforin and IFN- expression, and, unlike mature splenic NK 
cells, expressing the transcription factor Rorc (Satoh-Takayama 
et al., 2008; Luci et al., 2009; Sanos et al., 2009).
Rorc has been previously shown to be essential for thy-
mocyte survival (Sun et al., 2000), the development of lym-
phoid tissue inducer (LTi) cells (Eberl and Littman, 2003), 
and the differentiation of polarized T cells that express IL-17 
family  cytokines  (including  IL-22;  for  review  see  Ivanov   
et al., 2007). Curiously, intestinal CD3NKp46+ cells failed 
to  express  constitutive  or  inducible  IL-17A,  whereas  a 
CD127+NK1.1/lo subset clearly expressed IL-22 transcripts 
(Satoh-Takayama et al., 2008; Luci et al., 2009; Sanos et al., 
2009). Moreover, development of intestinal NKp46+IL-22+ 
cells required the presence of microflora and an intact Rorc 
gene (Satoh-Takayama et al., 2008; Luci et al., 2009; Sanos 
et al., 2009). These results identified a novel CD3NKp46+ 
cell subset in the gut that appeared to be hard-wired for rapid 
IL-22 production in response to microbial signatures. This 
pathway of innate IL-22 production appears evolutionarily 
conserved, as a CD3NKp44+ cell subset with similar prop-
erties has been identified in human lymph nodes and tonsils 
(Cella et al., 2009; Cupedo et al., 2009).JEM VOL. 207, February 15, 2010  275
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cells and a corresponding abrogation of IL-23–induced IL-22 
production (Fig. 1 C), consistent with earlier studies showing 
an essential role for Rorc in constitutive and inducible IL-22 
expression by gut CD3NKp46+ cells (Satoh-Takayama et al., 
2008; Luci et al., 2009; Sanos et al., 2009). Thus, differentia-
tion of gut CD3NKp46+ cells requires careful titration of 
E-box protein activity via Id2. These results demonstrate that 
the  development  and  normal  homeostasis  of  all  intestinal 
CD3NKp46+ cell subsets requires Id2, and reinforce the 
notion that intestinal CD3NKp46+ cells are developmen-
tally related to classical NK1.1+ NK cells and LTi cells.
Local overexpression of IL-15 expands intestinal 
CD3NKp46+ cells expressing NK1.1 cells but fails  
to perturb homeostasis of the CD127+NK1.1Rorc+ subset
We previously demonstrated that intestinal CD3NK1.1+ cells 
were strongly reduced in mice lacking IL-15 or the IL-2R 
chain (Satoh-Takayama et al., 2008), reflecting their similar 
cytokine dependency with classical NK cells found in other 
tissues. In contrast, homeostasis of intestinal CD3NKp46+ 
cells with the CD127+NK1.1 phenotype was not affected by 
an absence of IL-15 signaling. Although these observations 
rule out a role for IL-15 in the generation of the intestinal 
CD3NKp46+NK1.1 cell subset, it nevertheless remained 
possible that these cells might represent IL-15–responsive pre-
cursors that could be recruited to develop into NK1.1+ NK 
cells under conditions where IL-15 availability increases. To 
assess the local inductive effects of IL-15 on the composition of 
intestinal CD3NKp46+ cell subsets, we analyzed transgenic 
(Tg) mice in which IL-15 is overexpressed in the intestinal epi-
thelium (Ohta et al., 2002). In these IL-15 Tg mice, local pro-
duction  of  IL-15  has  been  previously  shown  to  augment 
numbers of CD8+ T cells that express NK1.1 (Ohta et al., 
2002). Total absolute numbers of LPLs were increased in IL-15 
Tg mice (WT mice, 6.5 ± 3.3 × 106 cells; IL-15 Tg mice, 
17.9 ± 9.4 × 106 cells), which increased the absolute numbers 
of intestinal lamina propria CD3NKp46+ cells two- to three-
fold compared with non-Tg littermates (WT mice, 1.5 ± 0.2 
× 105 CD3NKp46+ cells; IL-15 Tg mice, 4.3 ± 0.4 × 105 
CD3NKp46+ cells). When comparing CD127 versus NK1.1 
expression profiles, increased IL-15 availability strongly per-
turbed the relative frequencies of CD127/NK1.1 subsets with 
amplified percentages of NK1.1+CD127 cells in both the 
lamina propria and intraepithelial compartments (Fig. 2 A). 
This resulted in significantly increased absolute numbers of 
lamina  propria  NK1.1+CD127  cells  compared  with  WT 
mice (P = 0.09; Fig. 2 B). Remarkably, IL-15 overexpression 
had no effect on the absolute numbers of CD127+NK1.1 or 
CD127+NK1.1+ cells (Fig. 2 B). Moreover, Rorc expression and 
IL-23–induced IL-22 production from intestinal CD3NKp46+ 
cells were similar between WT and IL-15 Tg mice (Fig. 2, C 
and D). These results reinforce the concept that NK1.1 and 
NK1.1+ subsets of intestinal CD3NKp46+ cells represent two 
distinct and independent lineages with respect to IL-15 re-
sponsiveness. Nevertheless, these results do not formally rule 
out the possibility that the CD127+NK1.1Rorc+ subset of 
role for the transcriptional inhibitor Id2 in the homeostasis 
of these cells. Previous studies have shown that Id2 plays a 
critical role in the development of NK1.1+ NK cells (Yokota 
et al., 1999), and is essential for the development of LTi cells 
that express the transcription factor Rorc and coordinate pro-
grammed lymphoid tissue genesis during fetal life and induc-
ible lymphoid structures in adult mice (Eberl and Littman, 
2004).  By  comparing  lamina  propria  lymphocytes  (LPLs) 
from WT and Id2-deficient (Id2/) mice, we found that 
normal  development  of  all  intestinal  CD3NKp46+  cell 
subsets required Id2. Percentages of intestinal CD3NKp46+ 
cell subsets that differentially express CD127 and/or NK1.1 
were severely reduced in the absence of Id2 (Fig. 1 A), re-
sulting in dramatically reduced absolute numbers of these 
cells (WT mice, 1.5 ± 0.2 × 105 cells; Id2/ mice, 103 
cells). In contrast, intestinal T cell homeostasis in the lamina 
propria was minimally perturbed (Fig. S1), whereas Id2 de-
ficiency  markedly  reduced  the  frequency  of  splenic 
CD3NKp46+ cells (essentially NK1.1+ NK cells; Fig. 1 A), 
consistent with previous reports (Yokota et al., 1999; Kim 
et al., 2004; Boos et al., 2007).
Intestinal CD3NKp46+ cells that express Rorc can pro-
duce IL-22 after stimulation with IL-23 in vitro (Cella et al., 
2009). Id2 deficiency resulted in a strong reduction of RORt 
expression (Fig. 1 B) within residual intestinal CD3NKp46+ 
Figure 1.  Normal development of splenic and intestinal 
CD3NKp46+ cell subsets requires Id2. (A) NK1.1 versus CD127 expres-
sion on gated CD3NKp46+ splenocytes and small intestinal (SI) LPLs of 
WT and Id2/ mice. Subset frequencies are indicated in one representa-
tive experiment out of six performed. (B) RORt expression in intestinal 
CD3NKp46+ subsets in WT (bold line) and Id2/ mice (shaded histo-
gram). The dotted line depicts staining of CD3NKp46+ cells from  
Rorc/ mice. (C) IL-23–induced IL-22 expression in intestinal 
CD3NKp46+CD127+ cells from WT and Id2/ mice. Results indicate 
frequencies from one out of two independent experiments.276 Divergent roles for IL-7 and IL-15 in gut NKp46+ cell differentiation | Satoh-Takayama
the CD127+NK1.1 subset of intestinal CD3NKp46+ cells 
was strongly reduced in the absence of IL-7 compared with 
WT mice (Fig. 3, A and B). In contrast, the generation of 
intestinal CD3NK1.1+ cells was IL-7 independent (in fact, 
intestinal CD127NK1.1+ cells were significantly increased 
in Il7/ mice), thereby distinguishing these cells from thy-
mic NK cells (Vosshenrich et al., 2006). Intracellular stain-
ing revealed an absence of RORt expression in residual 
CD3NKp46+CD127+NK1.1 cells from IL-7–deficient 
mice (Fig. 3 C), demonstrating that IL-7 is required for nor-
mal development of this subset of Rorc+ intestinal cells.   
As such, NKp46+CD127+NK1.1 cells appear similar to 
fetal LTi cells in their strong IL-7 dependency (Meier et al., 
2007; Schmutz et al., 2009). Lastly, we demonstrate that 
intestinal CD3NKp46+ cells harbors IL-15–independent NK 
cell precursors.
IL-7 is critical for the homeostasis of the CD127+NK1.1 
subset of intestinal CD3NKp46+ cells that produces IL-22
Our previous studies demonstrated that development of the 
CD127+NK1.1 subset of intestinal CD3NKp46+ cells was 
dependent on c cytokine signaling (Satoh-Takayama et al., 
2008). As these cells express CD127, we assessed whether IL-7 
was required for their homeostasis. Although the frequency 
of intestinal CD3NKp46+ cells was unchanged in Il7/ 
mice (Fig. 3, A and B), absolute numbers were slightly but 
not significantly increased (WT mice, 1.5 ± 0.2 × 105 cells; 
Il7/ mice, 2.1 ± 0.9 × 105 cells; P = 0.24). We found that 
Figure 2.  Perturbed development of intestinal CD3GFP+ cell sub-
sets in Ncr1GFP/+ mice that overexpress IL-15 in the intestinal epi-
thelium. (A) NK1.1 versus CD127 expression on gated CD3GFP+ cells from 
small intestinal (SI) LPL and intraepithelial (IEL) compartments. Subset fre-
quencies are indicated. Representative results from one out of six indepen-
dent experiments are shown. (B) Absolute numbers of total CD3NKp46+ 
cells and CD127/NK1.1 subsets from small intestinal LPLs in WT and IL-15 
Tg mice (n = 5–8 mice of each genotype analyzed). Only CD127NK1.1+ 
cells were significantly increased in IL-15 Tg mice. Values are presented as 
means ± SD. (C) RORt expression in intestinal CD3NKp46+ subsets in WT 
(bold line) and IL-15 Tg mice (shaded histogram). The dotted line depicts 
staining of CD3NKp46+ cells from Rorc/ mice. (D) IL-22 production 
from intestinal CD3NKp46+ subsets in WT and IL-15 Tg mice. Results 
indicate frequencies from one out of three independent experiments.
Figure 3.  Altered development of intestinal CD3NKp46+ cells in 
Il7/ mice. (A) NK1.1 versus CD127 expression on gated CD3NKp46+ 
splenocytes and small intestinal (SI) LPLs of WT versus Il7/ mice. Subset 
frequencies are indicated in one representative experiment out of six 
performed. (B) Absolute numbers of total CD3NKp46+ cells and CD127/
NK1.1 subsets from small intestinal LPLs in WT and Il7/ mice (n = 6 
mice of each genotype analyzed). Significant differences are indicated. 
Values are presented as means ± SD. (C) RORt expression in the indi-
cated intestinal CD3NKp46+ subsets in WT (bold line) and Il7/ mice 
(shaded histogram). The dotted line depicts staining of CD3NKp46+ cells 
from Rorc/ mice. (D) IL-22 production from intestinal CD3NKp46+ 
subsets in WT and Il7/ mice. Results indicate frequencies from one out 
of three independent experiments.JEM VOL. 207, February 15, 2010  277
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loxP-flanked YFP reporter gene (Srinivas et al., 2001). In this 
context, YFP+ cells either express RORt or have expressed 
RORt at some previous stage in their developmental his-
tory.  We  confirmed  previous  results  (Eberl  and  Littman, 
2004) showing that all splenic T cells in these Tg mice ex-
press GFP (unpublished data), consistent with their devel-
opment from Rorc+ double-positive thymocytes. We next 
examined intestinal CD3NKp46+ cells in these mice. We 
found clear populations of YFP+NKp46+ cells in the intestinal 
lamina propria (51 ± 18%) and intraepithelial compartments 
(18 ± 12%) that were characterized by uniform CD127 ex-
pression and little or low NK1.1 expression (Fig. 4, A and B). 
This result is in accordance with our previous studies using   
Rorc-GFP mice that identified intestinal NKp46+ cell sub-
sets  (CD127+NK1.1/lo)  that  constitutively  express  Rorc 
(Lochner et al., 2008; Satoh-Takayama et al., 2008). In con-
trast, intestinal cells with the mature NK cell phenotype (iden-
tified as CD3NK1.1+CD127) were not represented in the 
YFP+NKp46+ subset (Fig. 4 B). Concerning tissues outside 
of the intestine, we further characterized YFP expression in 
classical NK cells (defined as CD3NKp46+NK1.1+CD127) 
from the bone marrow, spleen, liver and lymph nodes (Fig. 4 C). 
Similar to that observed in the gut, frequencies of YFP+ cells 
among NK cells from these tissues were extremely low (<1%). 
These results are inconsistent with the hypothesis that Rorc+ 
cells are obligatory precursors to the NK1.1+ cells within the 
various tissues analyzed, and argue against a major pathway 
IL-23–induced IL-22 production by intestinal CD3NKp46+ 
cells is abrogated in Il7/ mice (Fig. 3 D). These observa-
tions identify IL-7 as an essential cytokine for IL-22–produc-
ing CD3NKp46+Rorc+ cells in the gut. Moreover, they 
demonstrate that IL-7 and IL-15 have divergent roles in reg-
ulating the homeostasis of intestinal CD3NKp46+ cell sub-
sets via distinct precursors.
Relationships between intestinal CD3NKp46+ cell subsets: 
insights from fate mapping of Rorc-expressing 
hematopoietic progenitors
Although analysis of Rorc/ mice showed that this transcrip-
tion factor was not essential for normal NK cell development   
(Satoh-Takayama et al., 2008; Luci et al., 2009; Sanos et al., 
2009), previous studies in both humans and mice demon-
strated that lineage-negative populations of immature NK 
cells from diverse sources (lymph nodes, bone marrow, 
spleen, tonsils) did express Rorc and had NK cell precursor 
activity (Mebius et al., 1997; Chiossone et al., 2009; Cupedo 
et al., 2009; Hughes et al., 2009). As such, it remained pos-
sible that Rorc expression marked immature NK cells in the 
gut and elsewhere. To directly determine if Rorc+ cells in 
mice include precursors that can give rise to classical NK1.1+ 
cells, we performed a genetic cell fate–mapping experiment. 
Bacterial artificial chromosome Tg mice expressing the Cre 
recombinase under control of the Rorc(t) gene (Rorc(t)-CreTG 
mice; Lochner  et  al., 2008)  were  bred  to mice bearing a 
Figure 4.  Fate-mapping analysis of Rorc-expressing precursors. (A) Frequency of YFP+ cells in gated CD3NKp46+ cells from small intestinal (SI) 
LPLs and intraepithelial (IEL) cells. One representative experiment out of five is shown. Means of 51 ± 18% and 18 ± 12% YFP+ cells were detected in the 
LPL and intraepithelial compartments, respectively. (B) NK1.1 versus CD127 expression on YFP+ versus YFP subsets of intestinal CD3NKp46+ small intes-
tinal LPL and intraepithelial cells. (C) Frequency of YFP+ cells in gated CD3NK1.1+ cells from the indicated organs/tissues. Results indicate frequencies 
from one representative experiment out of five performed.278 Divergent roles for IL-7 and IL-15 in gut NKp46+ cell differentiation | Satoh-Takayama
Tokyo, Japan) and were generously provided by N. Cerf-Bensussan (Institut 
National de la Santé et de la Recherche Médicale U793, Paris, France). For 
fate-mapping studies, mice harboring a recombinant bacterial artificial chro-
mosome encoding RORt-Cre (Lochner et al., 2008) were crossed with 
mice  containing  a  loxP-flanked  EYFP  reporter  in  the  ROSA  locus 
(B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J; Srinivas et al., 2001). All mice were 
housed under specific pathogen-free conditions at the Laboratory Animal Fa-
cilities of the Institut Pasteur. Mice were analyzed at 6–12 wk of age. All ani-
mal experiments were approved by the Animal Care and Use Committee of 
the Institut Pasteur and were performed in accordance with French law.
Cell isolation and flow cytometric analysis. Total splenocytes and small 
intestinal LPLs were prepared for flow cytometry as previously described 
(Satoh-Takayama et al., 2008). The cell-surface phenotype was analyzed us-
ing commercially available fluorochrome-conjugated mAbs (BD and eBio-
science). Acquisitions were made using a flow cytometer (FACSCanto II; 
BD), interfaced to FACSDiva software (BD), and analyzed using FlowJo 
software (Tree Star, Inc.).
In vitro stimulation and intracellular cytokine staining. Total LPL prepa-
rations diluted in RPMI 1640 with 10% FCS (106 cells/well) were left unstimu-
lated or stimulated with 40 ng/ml IL-23 for 4 h in the presence of GolgiStop 
(BD). After surface staining and incubation with a fixable reagent (LIVE/DEAD; 
Invitrogen), cells were fixed in 4% paraformaldehyde and processed for intracel-
lular cytokine detection. Cells were stained with allophycocyanin-conjugated 
anti–IL-22 mAb (MH22B2.2; provided by J.-C. Renauld, Ludwig Institut, 
Brussels, Belgium) in staining buffer (0.1% saponin in HBSS) before extensive 
washing in PBS. For RORt detection, an anti–mouse/human RORt-PE 
(clone AFKJS-9; eBioscience) was used. Nonspecific staining of the anti-RORt 
was assessed using Rorc-deficient mice (Eberl et al., 2004).
Statistical analysis. Values are presented as means ± SD. The statistical sig-
nificance of differences between groups was determined by the unpaired 
Student’s t test. P < 0.05 was considered significant.
Online supplemental material. Fig. S1 shows the minor effect of Id2 defi-
ciency on T cell development in the lamina propria. Online supplemental mate-
rial is available at http://www.jem.org/cgi/content/full/jem.20092029/DC1.
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